{"id":"doi:10.1007/s13679-018-0300-4","kind":"review","title":"Future Pharmacotherapy for Obesity: New Anti-obesity Drugs on the Horizon","authors":["Gitanjali Srivastava","Caroline Margaret Apovian"],"author_count":2,"year":2018,"published":"2018-03-04","venue":"Current Obesity Reports","cited_by":232,"doi":"10.1007/s13679-018-0300-4","arxiv_id":null,"nct_id":null,"source_url":"https://doi.org/10.1007/s13679-018-0300-4","archive_url":"https://space-kitty.com/papers/doi:10.1007/s13679-018-0300-4","updated":null,"pmid":"29504049","pmcid":null,"openalex_id":"W2791667241","pdf_url":null,"abstract":null,"abstract_license":null,"license":null,"is_open_access":false,"retracted":false,"peer_reviewed":null,"categories":["Pharmacology and Obesity Treatment"],"details":null,"provenance":"openalex","attribution":"Metadata and citation counts: OpenAlex (CC0).","topics":[{"slug":"glp1-metabolic","name":"GLP-1 & Incretin Therapies","domain_slug":"medicine"}],"cited_in_dossiers":[]}